aspirin and dipyridamole (Roxane Laboratories, Inc.)
Welcome to the PulseAid listing for the aspirin and dipyridamole drug offered from Roxane Laboratories, Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Roxane Laboratories, Inc. |
| NON-PROPRIETARY NAME: | aspirin and dipyridamole |
| SUBSTANCE NAME: | ASPIRIN; DIPYRIDAMOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2015-06-24 |
| END MARKETING DATE: | 0000-00-00 |
aspirin and dipyridamole HUMAN PRESCRIPTION DRUG Details:
| Item Description | aspirin and dipyridamole from Roxane Laboratories, Inc. |
| LABELER NAME: | Roxane Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25; 200(mg/1; mg/1) |
| START MARKETING DATE: | 2015-06-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0054-0575_1f059a7a-8fd4-48a9-a36d-daa6dcc93c81 |
| PRODUCT NDC: | 0054-0575 |
| APPLICATION NUMBER: | NDA020884 |
Other ASPIRIN; DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers:
